Gem Aromatics Ltd (GEMAROMA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Gem Aromatics Ltd on NSE and BSE, with an AI summary of each filing.
Unaudited Financial results (Standalone & Consolidated) for September 30, 2026.
Financial Result · 31 Oct 2026, 11:58 pm
Submission of Investor Presentation in respect of Unaudited (Standalone & Consolidated) Financial Results for the quarter & half year ended September 30, 2026
Investor Presentation · 31 Oct 2026, 11:47 pm
Gem Aromatics Reports Q2FY27 Results and Expands Dahej Platform Gem Aromatics posted consolidated Q2FY27 revenue of Rs 104.0 Cr, up 16.2% YoY and 5.2% QoQ, driven by improved Mint product mix and Clove margin normalisation. EBITDA rose 158.4% YoY to Rs 7.9 Cr with margins expanding 416 bps to 7.6%. However, net loss stood at Rs 7.0 Cr due to Rs 9.5 Cr depreciation following the capitalisation of the ~Rs 265 Cr Dahej capex. Commercial shipments of cooling agents and Safranal commenced with revenue expected in Q3FY27, followed by MEHQ in Q4FY27.
Submission of Press Release in respect of Unaudited (Standalone & Consolidated) Financial Results for the quarter & half year ended September 30, 2026
Press Release · 31 Oct 2026, 11:45 pm
Gem Aromatics Reports Q2FY27 Results with Consolidated Revenue Growth and Margin Expansion Gem Aromatics reported Q2FY27 consolidated revenue of Rs 104.0 Cr, up 16.2% YoY from Rs 89.5 Cr, while EBITDA rose to Rs 7.9 Cr from Rs 3.0 Cr with margins expanding to 7.6% versus 3.4% in Q2FY26. Net loss widened to Rs 7.0 Cr compared to a loss of Rs 2.6 Cr in Q2FY26 due to elevated depreciation from the ramp-up of the Dahej facility. Wholly owned subsidiary Krystal Ingredients commenced production of cooling agents, Safranal, and Phenol Derivatives, with revenue contributions expected starting Q3FY27.
Outcome of the Board Meeting of Gem Aromatics Limited held on October 31, 2026
Outcome · 31 Oct 2026, 11:04 pm
Gem Aromatics Reports Q2 FY27 Results with Consolidated Losses and Accounting Policy Change For Q2 ended 30th Sep'26, Gem Aromatics reported consolidated revenue from operations of ₹1,039.99m, up 16.17% YoY and 5.21% QoQ. However, consolidated net loss widened to ₹70.15m compared to a loss of ₹25.79m in Sep'25, hit by higher raw material and depreciation costs. Standalone net profit rose 116.56% YoY to ₹89.03m. The company transitioned its inventory valuation method prospectively from Weighted Average Cost to FIFO effective 1st Apr'26, citing improved cost reflection across complex continuous distillation cycles.
Gem Aromatics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 31 Oct 2026, 11:01 pm
Gem Aromatics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 1,040 (+16.2% YoY | +5.2% QoQ) ■ EBITDA: 78.7 (+158.4% YoY | +138.0% QoQ) ■ EBITDA Margin (%): 7.6 (+416 bps YoY | +422 bps QoQ) ■ PAT: -70.2 (-172.0% YoY | +10.9% QoQ) ■ EPS (INR): -1.29 (-3125.0% YoY | +17.3% QoQ)
Gem Aromatics Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 31 Oct 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 31 Oct 2026, 5:30 am
Gem Aromatics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....
Intimation · 31 Oct 2026, 5:30 am
Gem Aromatics Board Meeting Scheduled for 31st Oct'26 to Consider Q2 Results Gem Aromatics Limited's Board of Directors will meet on 31st Oct'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for dealing in company securities remains closed for designated persons and their immediate relatives until 48 hours after the declaration of the financial results.
Intimation of Resignation of Senior Management Personnel
Change in Management · 30 Sept 2026, 8:43 pm
Gem Aromatics Announces Resignation of GM R&D Kiran Sirsalmath Gem Aromatics Limited announced that Dr. Kiran Sirsalmath, General Manager – Research & Development and Senior Management Personnel, has resigned due to personal reasons and career prospects. His cessation is effective from the close of business hours on 30th Sep'26.
Approval for conversion of inter-company loan into equity shares of Krystal Ingredients Private Limited (Wholly Owned Subsidiary).
Others (Uncategorized) · 22 Sept 2026, 11:36 pm
Gem Aromatics Approves Loan Conversion into Krystal Ingredients Equity Gem Aromatics' Board approved converting pre-existing inter-company loans into equity shares of its wholly owned subsidiary, Krystal Ingredients Private Limited, on 22nd Sep'26. The transaction involves no fresh cash infusion, with shares issued at ₹47,710 each (₹10 face value, ₹47,700 premium), maintaining Gem's 100% shareholding. The conversion aims to strengthen Krystal's capital base and support growth. Krystal, an aroma and specialty chemicals manufacturer, reported FY26 turnover of ₹32.33 crore and net worth of ₹59.86 crore, up sharply from ₹2.90 crore in FY25.
Please find enclosed Revised Annual Report for the financial year 2025-26.
Others (Uncategorized) · 22 Sept 2026, 11:20 pm
Transcript of Conference Call for Investors and Analyst
Transcript · 20 Aug 2026, 5:44 pm
Voting Results and Scrutinizer''s Report of the 29th Annual General Meeting of the Company held on August 19, 2026.
Annual General Meeting · 20 Aug 2026, 2:32 am
Proceedings of the Annual General Meeting held on August 19, 2026.
Annual General Meeting · 20 Aug 2026, 2:06 am
Audio Recording of Conference Call for Investor and Analysts
Audio / Video · 15 Aug 2026, 12:08 am
Gem Aromatics Makes Q1 FY27 Investor Call Recording Available Gem Aromatics announced that the audio recording for its Q1 FY27 investor and analyst conference call is now available. The virtual call was held on Fri, 14 Aug'26, to discuss the company's quarterly results. Interested parties can access the recording on the company's website.
Submission of Press Release in respect of Unaudited (Standalone & Consolidated) Financial Results for the quarter ended June 30, 2026.
Press Release · 14 Aug 2026, 1:14 am
Gem Aromatics Q1FY27: Revenue Grows, but Higher Costs and Dahej Capex Hit Profitability Gem Aromatics reported weak consolidated Q1FY27 results, with revenue up 12.8% YoY to ₹98.9 Cr but down 10.5% QoQ. Profitability was severely impacted by higher raw material costs, product mix, and ₹9.1 Cr depreciation from the new Dahej facility. EBITDA fell 77.7% YoY to ₹3.3 Cr, with margins collapsing by 1361 bps to 3.3%. The company posted a net loss of ₹7.9 Cr versus a ₹8.0 Cr profit in Q1FY26. Management expects gradual margin improvement as new, higher-value products scale up.
Submission of Investor Presentation in respect of Unaudited (Standalone & Consolidated) Financial Results for the quarter ended June 30, 2026
Investor Presentation · 14 Aug 2026, 12:48 am
Gem Aromatics: Q1FY27 Revenue Grows YoY, But Dahej Capex Hits Profitability For Q1FY27, consolidated revenue grew 13% YoY to Rs 98.9 Cr. However, higher raw material costs and increased operating expenses from the newly commissioned Dahej facility compressed margins. Gross margin fell to 16.7% from 29.5% YoY, and EBITDA margin dropped to 3.3% from 16.9%. Consequently, the company reported a net loss of Rs 7.9 Cr, versus a profit of Rs 8.0 Cr in Q1FY26, primarily due to Rs 9.1 Cr in depreciation charges post-capitalization of the Rs 265 Cr Dahej capex.
Outcome of the Board Meeting of Gem Aromatics Limited held on August 13, 2026.
Outcome · 13 Aug 2026, 11:22 pm
Gem Aromatics Posts Q1 FY27 Net Loss; Changes Inventory Valuation Method Gem Aromatics reported a consolidated net loss of ₹78.74 million for Q1 FY27, a significant decline from a ₹79.84 million profit in Q1 FY26. Consolidated revenue from operations grew 12.8% YoY to ₹988.50 million. The company switched its inventory valuation method from Weighted Average Cost to First-In, First-Out (FIFO) effective 1-Apr'26, applied prospectively. The change resulted in higher costs of materials consumed, contributing to the quarterly loss. QoQ, revenue fell 10.5% while the company swung to a loss from a ₹10.13 million profit.
Intimation of Conference call with Investors and Analysts.
Intimation · 14 Aug 2026, 4:00 pm
Gem Aromatics Schedules Q1FY27 Investor and Analyst Conference Call Gem Aromatics Limited (NSE: GEMAROMA) will host an investor and analyst conference call on Fri, 14th Aug'26, at 4:00 p.m. IST. The management team, including the MD & CEO Yash Parekh and CFO Kaksha Parekh, will discuss the unaudited financial results for the quarter ended 30th Jun'26. This call provides a platform for stakeholders to engage with leadership regarding the company's Q1FY27 performance and outlook.
Gem Aromatics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Standalone and Consolidated Unaudited ....
Intimation · 13 Aug 2026, 5:30 am
Gem Aromatics Schedules Board Meeting for Q1 FY27 Results Gem Aromatics (NSE: GEMAROMA) will hold a Board of Directors meeting on 13 Aug'26. The agenda includes the consideration and approval of the standalone and consolidated unaudited financial results for the quarter ended 30 Jun'26. Consequently, the trading window for designated persons is closed from 01 Jul'26 until 48 hours after the results are declared.
Letter to Shareholders- Weblink of AGM Notice and Annual Report.
Annual General Meeting · 29 Jul 2026, 12:20 am
Pursuant to the provisions of Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the 29th Annual General Meeting ....
Annual General Meeting · 28 Jul 2026, 6:48 pm
Annual Report for FY 2025-26
Others (Uncategorized) · 28 Jul 2026, 6:39 pm
Appointment of Secretarial Auditor & Re-appointment of Internal Auditor
Change in Management · 23 Jun 2026, 11:18 pm
Gem Aromatics Approves Brazil Subsidiary and Key Auditor Appointments Gem Aromatics' board on 23 Jun'26 approved incorporating a wholly-owned subsidiary in Brazil to distribute its chemical products. The company plans an equity investment up to ₹2 crore and a standby letter of credit up to ₹15 crore for the new entity. Additionally, the board re-appointed M/s. RANK & Associates as Internal Auditor for FY27 and appointed M/s. N. L. Bhatia & Associates as Secretarial Auditor for a five-year term from FY27 to FY31, subject to shareholder approval.
Outcome of Board Meeting dated June 23, 2026
Others (Uncategorized) · 23 Jun 2026, 11:13 pm
Gem Aromatics To Incorporate Wholly-Owned Subsidiary in Brazil On 23 Jun'26, Gem Aromatics' board approved the incorporation of a wholly-owned subsidiary in Brazil to distribute its chemical products. The company plans an equity investment of up to ₹2 crore via Overseas Direct Investment and a standby letter of credit up to ₹15 crore. The board also re-appointed M/s. RANK & Associates as Internal Auditor for FY27 and appointed M/s. N. L. Bhatia & Associates as Secretarial Auditors for a five-year term commencing FY27, subject to member approval.